Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.49 AUD | +5.96% | +3.32% | +6.41% |
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- With a 2024 P/E ratio at 27.26 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
Ratings chart - Surperformance
Sector: Investment Management & Fund Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+6.41% | 475M | - | ||
-6.03% | 113B | A- | ||
-3.98% | 87.91B | C+ | ||
+20.42% | 63.85B | C | ||
+5.29% | 61.9B | - | B+ | |
+10.12% | 42.86B | C+ | ||
+7.95% | 40.84B | A- | ||
+18.92% | 34.58B | A- | ||
+5.88% | 25.46B | B | ||
-5.25% | 22.13B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- QAL Stock
- Ratings Qualitas Limited